Unilever Research & Development, Vlaardingen, Netherlands.
Am J Clin Nutr. 2011 Nov;94(5):1171-81. doi: 10.3945/ajcn.111.020321. Epub 2011 Oct 12.
Extracts from Hoodia gordonii have been shown to decrease food intakes and body weights in animals and were proposed as a food supplement or ingredient for weight management.
We assessed the safety and efficacy of a 15-d repeated consumption of H. gordonii purified extract (HgPE) relative to a placebo in humans.
Healthy, overweight women, who were stratified by percentage body fat, received either HgPE (n = 25) or a placebo (n = 24) for 15 d. Subjects were resident in a clinic for a 4-d run-in period and a 15-d treatment period in which they received 2 servings/d of 1110 mg HgPE or a placebo formulated in a yogurt drink 1 h before breakfast and dinner. Subjects were otherwise allowed to eat ad libitum from standardized menus.
There were no serious adverse events, but HgPE was less well tolerated than was the placebo because of episodes of nausea, emesis, and disturbances of skin sensation. Blood pressure, pulse, heart rate, bilirubin, and alkaline phosphatase showed significant (P < 0.05) increases in the HgPE group. Mean effects on ad libitum energy intakes and body weights did not differ significantly between the HgPE- and placebo-treatment groups (P > 0.05).
In comparison with a matched placebo, the consumption of HgPE for 15 d appeared to be associated with significant adverse changes in some vital signs and laboratory parameters. HgPE was less well tolerated than was the placebo and did not show any significant effects on energy intakes or body weights relative to the placebo. This trial was registered at clinicaltrials.gov as NCT01306422.
霍多利亚(Hoodia gordonii)的提取物已被证明可减少动物的食物摄入量和体重,并被提议作为一种食品补充剂或成分用于体重管理。
我们评估了 15 天重复摄入霍多利亚纯化提取物(HgPE)相对于安慰剂在人体中的安全性和功效。
健康超重的女性,根据体脂百分比分层,接受 HgPE(n = 25)或安慰剂(n = 24)治疗 15 天。研究对象在诊所居住 4 天的适应期和 15 天的治疗期内,在早餐和晚餐前 1 小时服用 2 份 1110 毫克 HgPE 或安慰剂,配方为酸奶饮料。研究对象可以自由食用标准化菜单。
没有严重的不良事件,但由于恶心、呕吐和皮肤感觉障碍,HgPE 的耐受性不如安慰剂。HgPE 组的血压、脉搏、心率、胆红素和碱性磷酸酶均显著升高(P < 0.05)。HgPE 组和安慰剂组之间的自由能量摄入量和体重的平均影响无显著差异(P > 0.05)。
与匹配的安慰剂相比,15 天内服用 HgPE 似乎与一些生命体征和实验室参数的显著不良变化有关。HgPE 的耐受性不如安慰剂,与安慰剂相比,HgPE 对能量摄入或体重没有任何显著影响。该试验在 clinicaltrials.gov 上注册为 NCT01306422。